Position in ABT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,717,709
+$1,185,433 QoQ
Shares Held
85,053
+33.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#566
of 2,959 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GROUPAMA ASSET MANAGMENT holds $82,555,674 across 7 Medical Devices names. ABT ranks #2 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
1,571,750 | $67,082,290 | |
| 2 | ABT |
Abbott Laboratories
This page
|
85,053 | $7,717,709 | |
| 3 | MDT |
Medtronic plc
|
53,429 | $4,179,750 | |
| 4 | EW |
Edwards Lifesciences Corp
|
21,950 | $1,985,597 | |
| 5 | PODD |
Insulet Corp
|
3,918 | $596,515 | |
| 6 | DXCM |
Dexcom Inc
|
7,973 | $536,981 | |
| 7 | SYK |
Stryker Corp
|
1,451 | $456,832 |
All Filings in ABT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,717,709 | 85,053 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,532,276 | 63,624 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $8,033,845 | 64,122 | Shares | Sole | 2026-02-27 | |
| 2025-09-30 | $7,947,731 | 59,338 | Shares | Sole | 2025-12-01 | |
| 2025-06-30 | $8,445,676 | 62,096 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,551,414 | 64,466 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,661,737 | 76,578 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $26,045,355 | 228,448 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $19,419,843 | 186,891 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,524,002 | 198,170 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $26,628,134 | 241,920 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||